Hyperuricemia and other Cardiovascular Risk Factors
The prevalence of clinical gout is rather low in Finland. In most studies concerning the epidemiology of gout the prevalence rates have varied from 0.3 to 3.0% in adult population. Persons having certain chronic diseases are allowed free drug therapy according to the Sickness Insurance Act of Finland. Gout is one of these chronic diseases. According to the latest statistics 0.1% of men and 0.03% of women aged 35–64 years are allowed free drug therapy for gout(1). On the other hand, the serum uric acid concentration of Finnish population is not strikingly lower than in other countries (2).
KeywordsUric Acid Cardiovascular Risk Factor Serum Uric Acid Serum Uric Acid Level Serum Uric Acid Concentration
Unable to display preview. Download preview PDF.
- 1.Statistics on drugs reimbursed in full 30.6.1974. Social Insurance Institution’s publication T6:7, Helsinki 1974. (in Finnish)Google Scholar
- 2.Isomäki, H.: Hyp:eruricaemia in northern Finland. Ann. clin. Res. suppl. 1. 1969.Google Scholar
- 7.Pyörälä, K. et al.: Social Insurance Institution’s coronary heart disease study. Social Insurance Institution’s publications AL 1, Helsinki 1975. (in Finnish with English summary)Google Scholar
- 8.Takkunen, H.: Iron deficiency in the Finnish adult population. Scand. J. Haemat. suppl. 25, 1976.Google Scholar
- 9.Uric acid method. In Auto-Analyzer Manual. Technicon Instruments Corp. Chauncey, New York 1965.Google Scholar
- 10.Andrews, F.M. et al.: “Multiple classification analysis”. 2nd ed. Ann Arbor, Institute for Social Research, The University of Michigan, 1973.Google Scholar